+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

High Potency APIs /HPAPI - Market Analysis, Trends, and Forecasts

  • ID: 4805562
  • Report
  • October 2019
  • Region: Global
  • 180 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Abbvie
  • Bayer Ag
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Merck & Co.
  • Mylan Pharmaceuticals
  • MORE
The High Potency APIs /HPAPI market worldwide is projected to grow by US$13.4 Billion, driven by a compounded growth of 8.3%. Innovative, one of the segments analyzed and sized in this study, displays the potential to grow at over 8.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$21 Billion by the year 2025, Innovative will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 9.5% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$615.4 Million to the region's size and clout in the next 5 to 6 years. Over US$624 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Innovative will reach a market size of US$1.6 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 8% over the next couple of years and add approximately US$2.3 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • AbbVie, Inc.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Merck & Co., Inc.
  • Mylan Pharmaceuticals, Inc.
  • Novartis International AG
  • Pfizer, Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbvie
  • Bayer Ag
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Merck & Co.
  • Mylan Pharmaceuticals
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

High Potency APIs /HPAPI Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: High Potency APIs /HPAPI Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: High Potency APIs /HPAPI Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: High Potency APIs /HPAPI Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Innovative (Type) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Innovative (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Innovative (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Generic (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Generic (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Generic (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Captive (Manufacturer) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Captive (Manufacturer) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Captive (Manufacturer) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Merchant (Manufacturer) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Merchant (Manufacturer) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Merchant (Manufacturer) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Oncology (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 17: Oncology (Application) Global Historic Analysis in US$ Million by Region/Country: 2009-2017

TABLE 18: Oncology (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Hormonal Disorders (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025

TABLE 20: Hormonal Disorders (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017

TABLE 21: Hormonal Disorders (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025

TABLE 22: Glaucoma (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025

TABLE 23: Glaucoma (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017

TABLE 24: Glaucoma (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: Other Therapeutic Applications (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025

TABLE 26: Other Therapeutic Applications (Application) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017

TABLE 27: Other Therapeutic Applications (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US High Potency APIs /HPAPI Market Share (in %) by Company: 2019 & 2025

TABLE 28: United States High Potency APIs /HPAPI Market Estimates and Projections in US$ Million by Type: 2018 to 2025

TABLE 29: High Potency APIs /HPAPI Market in the United States by Type: A Historic Review in US$ Million for 2009-2017

TABLE 30: United States High Potency APIs /HPAPI Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 31: United States High Potency APIs /HPAPI Market Estimates and Projections in US$ Million by Manufacturer: 2018 to 2025

TABLE 32: High Potency APIs /HPAPI Market in the United States by Manufacturer: A Historic Review in US$ Million for 2009-2017

TABLE 33: United States High Potency APIs /HPAPI Market Share Breakdown by Manufacturer: 2009 VS 2019 VS 2025

TABLE 34: United States High Potency APIs /HPAPI Latent Demand Forecasts in US$ Million by Application: 2018 to 2025

TABLE 35: High Potency APIs /HPAPI Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017

TABLE 36: High Potency APIs /HPAPI Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025

CANADA

TABLE 37: Canadian High Potency APIs /HPAPI Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025

TABLE 38: Canadian High Potency APIs /HPAPI Historic Market Review by Type in US$ Million: 2009-2017

TABLE 39: High Potency APIs /HPAPI Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 40: Canadian High Potency APIs /HPAPI Market Estimates and Forecasts in US$ Million by Manufacturer: 2018 to 2025

TABLE 41: Canadian High Potency APIs /HPAPI Historic Market Review by Manufacturer in US$ Million: 2009-2017

TABLE 42: High Potency APIs /HPAPI Market in Canada: Percentage Share Breakdown of Sales by Manufacturer for 2009, 2019, and 2025

TABLE 43: Canadian High Potency APIs /HPAPI Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025

TABLE 44: High Potency APIs /HPAPI Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017

TABLE 45: Canadian High Potency APIs /HPAPI Market Share Analysis by Application: 2009 VS 2019 VS 2025

JAPAN

TABLE 46: Japanese Market for High Potency APIs /HPAPI: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025

TABLE 47: High Potency APIs /HPAPI Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017

TABLE 48: Japanese High Potency APIs /HPAPI Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 49: Japanese Market for High Potency APIs /HPAPI: Annual Sales Estimates and Projections in US$ Million by Manufacturer for the Period 2018-2025

TABLE 50: High Potency APIs /HPAPI Market in Japan: Historic Sales Analysis in US$ Million by Manufacturer for the Period 2009-2017

TABLE 51: Japanese High Potency APIs /HPAPI Market Share Analysis by Manufacturer: 2009 VS 2019 VS 2025

TABLE 52: Japanese Demand Estimates and Forecasts for High Potency APIs /HPAPI in US$ Million by Application: 2018 to 2025

TABLE 53: Japanese High Potency APIs /HPAPI Market in US$ Million by Application: 2009-2017

TABLE 54: High Potency APIs /HPAPI Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025

CHINA

TABLE 55: Chinese High Potency APIs /HPAPI Market Growth Prospects in US$ Million by Type for the Period 2018-2025

TABLE 56: High Potency APIs /HPAPI Historic Market Analysis in China in US$ Million by Type: 2009-2017

TABLE 57: Chinese High Potency APIs /HPAPI Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 58: Chinese High Potency APIs /HPAPI Market Growth Prospects in US$ Million by Manufacturer for the Period 2018-2025

TABLE 59: High Potency APIs /HPAPI Historic Market Analysis in China in US$ Million by Manufacturer: 2009-2017

TABLE 60: Chinese High Potency APIs /HPAPI Market by Manufacturer: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 61: Chinese Demand for High Potency APIs /HPAPI in US$ Million by Application: 2018 to 2025

TABLE 62: High Potency APIs /HPAPI Market Review in China in US$ Million by Application: 2009-2017

TABLE 63: Chinese High Potency APIs /HPAPI Market Share Breakdown by Application: 2009 VS 2019 VS 2025

EUROPE

Market Facts & Figures

European High Potency APIs /HPAPI Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 64: European High Potency APIs /HPAPI Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 65: High Potency APIs /HPAPI Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 66: European High Potency APIs /HPAPI Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 67: European High Potency APIs /HPAPI Market Estimates and Forecasts in US$ Million by Type: 2018-2025

TABLE 68: High Potency APIs /HPAPI Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017

TABLE 69: European High Potency APIs /HPAPI Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 70: European High Potency APIs /HPAPI Market Estimates and Forecasts in US$ Million by Manufacturer: 2018-2025

TABLE 71: High Potency APIs /HPAPI Market in Europe in US$ Million by Manufacturer: A Historic Review for the Period 2009-2017

TABLE 72: European High Potency APIs /HPAPI Market Share Breakdown by Manufacturer: 2009 VS 2019 VS 2025

TABLE 73: European High Potency APIs /HPAPI Addressable Market Opportunity in US$ Million by Application: 2018-2025

TABLE 74: High Potency APIs /HPAPI Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017

TABLE 75: European High Potency APIs /HPAPI Market Share Analysis by Application: 2009 VS 2019 VS 2025

FRANCE

TABLE 76: High Potency APIs /HPAPI Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 77: French High Potency APIs /HPAPI Historic Market Scenario in US$ Million by Type: 2009-2017

TABLE 78: French High Potency APIs /HPAPI Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 79: High Potency APIs /HPAPI Market in France by Manufacturer: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 80: French High Potency APIs /HPAPI Historic Market Scenario in US$ Million by Manufacturer: 2009-2017

TABLE 81: French High Potency APIs /HPAPI Market Share Analysis by Manufacturer: 2009 VS 2019 VS 2025

TABLE 82: High Potency APIs /HPAPI Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025

TABLE 83: French High Potency APIs /HPAPI Historic Market Review in US$ Million by Application: 2009-2017

TABLE 84: French High Potency APIs /HPAPI Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025

GERMANY

TABLE 85: High Potency APIs /HPAPI Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 86: German High Potency APIs /HPAPI Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 87: German High Potency APIs /HPAPI Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 88: High Potency APIs /HPAPI Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Manufacturer for the Period 2018-2025

TABLE 89: German High Potency APIs /HPAPI Historic Market Analysis in US$ Million by Manufacturer: 2009-2017

TABLE 90: German High Potency APIs /HPAPI Market Share Breakdown by Manufacturer: 2009 VS 2019 VS 2025

TABLE 91: High Potency APIs /HPAPI Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025

TABLE 92: German High Potency APIs /HPAPI Market in Retrospect in US$ Million by Application: 2009-2017

TABLE 93: High Potency APIs /HPAPI Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025

ITALY

TABLE 94: Italian High Potency APIs /HPAPI Market Growth Prospects in US$ Million by Type for the Period 2018-2025

TABLE 95: High Potency APIs /HPAPI Historic Market Analysis in Italy in US$ Million by Type: 2009-2017

TABLE 96: Italian High Potency APIs /HPAPI Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 97: Italian High Potency APIs /HPAPI Market Growth Prospects in US$ Million by Manufacturer for the Period 2018-2025

TABLE 98: High Potency APIs /HPAPI Historic Market Analysis in Italy in US$ Million by Manufacturer: 2009-2017

TABLE 99: Italian High Potency APIs /HPAPI Market by Manufacturer: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 100: Italian Demand for High Potency APIs /HPAPI in US$ Million by Application: 2018 to 2025

TABLE 101: High Potency APIs /HPAPI Market Review in Italy in US$ Million by Application: 2009-2017

TABLE 102: Italian High Potency APIs /HPAPI Market Share Breakdown by Application: 2009 VS 2019 VS 2025

UNITED KINGDOM

TABLE 103: United Kingdom Market for High Potency APIs /HPAPI: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025

TABLE 104: High Potency APIs /HPAPI Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017

TABLE 105: United Kingdom High Potency APIs /HPAPI Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 106: United Kingdom Market for High Potency APIs /HPAPI: Annual Sales Estimates and Projections in US$ Million by Manufacturer for the Period 2018-2025

TABLE 107: High Potency APIs /HPAPI Market in the United Kingdom: Historic Sales Analysis in US$ Million by Manufacturer for the Period 2009-2017

TABLE 108: United Kingdom High Potency APIs /HPAPI Market Share Analysis by Manufacturer: 2009 VS 2019 VS 2025

TABLE 109: United Kingdom Demand Estimates and Forecasts for High Potency APIs /HPAPI in US$ Million by Application: 2018 to 2025

TABLE 110: United Kingdom High Potency APIs /HPAPI Market in US$ Million by Application: 2009-2017

TABLE 111: High Potency APIs /HPAPI Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 112: Rest of Europe High Potency APIs /HPAPI Market Estimates and Forecasts in US$ Million by Type: 2018-2025

TABLE 113: High Potency APIs /HPAPI Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017

TABLE 114: Rest of Europe High Potency APIs /HPAPI Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 115: Rest of Europe High Potency APIs /HPAPI Market Estimates and Forecasts in US$ Million by Manufacturer: 2018-2025

TABLE 116: High Potency APIs /HPAPI Market in Rest of Europe in US$ Million by Manufacturer: A Historic Review for the Period 2009-2017

TABLE 117: Rest of Europe High Potency APIs /HPAPI Market Share Breakdown by Manufacturer: 2009 VS 2019 VS 2025

TABLE 118: Rest of Europe High Potency APIs /HPAPI Addressable Market Opportunity in US$ Million by Application: 2018-2025

TABLE 119: High Potency APIs /HPAPI Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017

TABLE 120: Rest of Europe High Potency APIs /HPAPI Market Share Analysis by Application: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 121: High Potency APIs /HPAPI Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 122: Asia-Pacific High Potency APIs /HPAPI Historic Market Scenario in US$ Million by Type: 2009-2017

TABLE 123: Asia-Pacific High Potency APIs /HPAPI Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 124: High Potency APIs /HPAPI Market in Asia-Pacific by Manufacturer: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 125: Asia-Pacific High Potency APIs /HPAPI Historic Market Scenario in US$ Million by Manufacturer: 2009-2017

TABLE 126: Asia-Pacific High Potency APIs /HPAPI Market Share Analysis by Manufacturer: 2009 VS 2019 VS 2025

TABLE 127: High Potency APIs /HPAPI Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025

TABLE 128: Asia-Pacific High Potency APIs /HPAPI Historic Market Review in US$ Million by Application: 2009-2017

TABLE 129: Asia-Pacific High Potency APIs /HPAPI Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025

REST OF WORLD

TABLE 130: Rest of World High Potency APIs /HPAPI Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025

TABLE 131: Rest of World High Potency APIs /HPAPI Historic Market Review by Type in US$ Million: 2009-2017

TABLE 132: High Potency APIs /HPAPI Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 133: Rest of World High Potency APIs /HPAPI Market Estimates and Forecasts in US$ Million by Manufacturer: 2018 to 2025

TABLE 134: Rest of World High Potency APIs /HPAPI Historic Market Review by Manufacturer in US$ Million: 2009-2017

TABLE 135: High Potency APIs /HPAPI Market in Rest of World: Percentage Share Breakdown of Sales by Manufacturer for 2009, 2019, and 2025

TABLE 136: Rest of World High Potency APIs /HPAPI Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025

TABLE 137: High Potency APIs /HPAPI Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017

TABLE 138: Rest of World High Potency APIs /HPAPI Market Share Analysis by Application: 2009 VS 2019 VS 2025

IV. COMPETITION

ABBVIE

BAYER AG

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

BRISTOL-MYERS SQUIBB COMPANY

ELI LILLY AND COMPANY

F. HOFFMANN-LA ROCHE AG

MERCK & CO.

MYLAN PHARMACEUTICALS

NOVARTIS INTERNATIONAL AG

PFIZER

SANOFI SA

TEVA PHARMACEUTICAL INDUSTRIES

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbvie
  • Bayer Ag
  • Boehringer Ingelheim International Gmbh
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Merck & Co.
  • Mylan Pharmaceuticals
  • Novartis International Ag
  • Pfizer
  • Sanofi Sa
  • Teva Pharmaceutical Industries
Note: Product cover images may vary from those shown
Adroll
adroll